Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease

Ilaria Guidi, Daniela Galimberti, Silvia Lonati, Cristina Novembrino, Fabrizia Bamonti, Marco Tiriticco, Chiara Fenoglio, Eliana Venturelli, Pierluigi Baron, Nereo Bresolin, Elio Scarpini

Research output: Contribution to journalArticle

Abstract

Increasing evidence supports a role of oxidative imbalance, characterized by impaired antioxidant enzymatic activity and increased reactive oxygen species (ROS) production, in mild cognitive impairment (MCI) and Alzheimer's disease (AD) pathogenesis. Hyperhomocysteinemia, another risk factor for AD, also contributes to oxidative damage. Plasma total homocysteine (tHcy) and ROS levels, and total antioxidant capacity (TAC) were determined in 71 AD, 36 MCI and 28 vascular dementia (VaD) patients as well as in 44 age-matched controls. tHcy levels were significantly increased in patients with AD and VaD an a trend towards an increase in multiple domain MCI was observed. TAC was significantly decreased in AD as well as MCI, but not in VaD patients. In AD patients, a negative correlation was found between TAC and disease duration. ROS levels did not differ among groups, but were correlated with age. In conclusion, a pattern characterized by increased tHcy levels and decreased TAC is present in AD as well as MCI patients. While increased tHcy levels were also found in VaD, TAC modifications occur specifically in AD. ROS levels appear to be correlated with age rather than with a specific dementing disorder, thus leading to the hypothesis that oxidative imbalance observed in AD could be due to a decreased TAC.

Original languageEnglish
Pages (from-to)262-269
Number of pages8
JournalNeurobiology of Aging
Volume27
Issue number2
DOIs
Publication statusPublished - Feb 2006

Fingerprint

Alzheimer Disease
Antioxidants
Vascular Dementia
Homocysteine
Reactive Oxygen Species
Cognitive Dysfunction
Hyperhomocysteinemia

Keywords

  • Alzheimer's disease
  • Mild cognitive impairment
  • Reactive oxygen species
  • Total antioxidant capacity
  • Total plasma homocysteine

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. / Guidi, Ilaria; Galimberti, Daniela; Lonati, Silvia; Novembrino, Cristina; Bamonti, Fabrizia; Tiriticco, Marco; Fenoglio, Chiara; Venturelli, Eliana; Baron, Pierluigi; Bresolin, Nereo; Scarpini, Elio.

In: Neurobiology of Aging, Vol. 27, No. 2, 02.2006, p. 262-269.

Research output: Contribution to journalArticle

Guidi, Ilaria ; Galimberti, Daniela ; Lonati, Silvia ; Novembrino, Cristina ; Bamonti, Fabrizia ; Tiriticco, Marco ; Fenoglio, Chiara ; Venturelli, Eliana ; Baron, Pierluigi ; Bresolin, Nereo ; Scarpini, Elio. / Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. In: Neurobiology of Aging. 2006 ; Vol. 27, No. 2. pp. 262-269.
@article{b59d7f9ae816405bbe84738f5b94f09b,
title = "Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease",
abstract = "Increasing evidence supports a role of oxidative imbalance, characterized by impaired antioxidant enzymatic activity and increased reactive oxygen species (ROS) production, in mild cognitive impairment (MCI) and Alzheimer's disease (AD) pathogenesis. Hyperhomocysteinemia, another risk factor for AD, also contributes to oxidative damage. Plasma total homocysteine (tHcy) and ROS levels, and total antioxidant capacity (TAC) were determined in 71 AD, 36 MCI and 28 vascular dementia (VaD) patients as well as in 44 age-matched controls. tHcy levels were significantly increased in patients with AD and VaD an a trend towards an increase in multiple domain MCI was observed. TAC was significantly decreased in AD as well as MCI, but not in VaD patients. In AD patients, a negative correlation was found between TAC and disease duration. ROS levels did not differ among groups, but were correlated with age. In conclusion, a pattern characterized by increased tHcy levels and decreased TAC is present in AD as well as MCI patients. While increased tHcy levels were also found in VaD, TAC modifications occur specifically in AD. ROS levels appear to be correlated with age rather than with a specific dementing disorder, thus leading to the hypothesis that oxidative imbalance observed in AD could be due to a decreased TAC.",
keywords = "Alzheimer's disease, Mild cognitive impairment, Reactive oxygen species, Total antioxidant capacity, Total plasma homocysteine",
author = "Ilaria Guidi and Daniela Galimberti and Silvia Lonati and Cristina Novembrino and Fabrizia Bamonti and Marco Tiriticco and Chiara Fenoglio and Eliana Venturelli and Pierluigi Baron and Nereo Bresolin and Elio Scarpini",
year = "2006",
month = "2",
doi = "10.1016/j.neurobiolaging.2005.01.001",
language = "English",
volume = "27",
pages = "262--269",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease

AU - Guidi, Ilaria

AU - Galimberti, Daniela

AU - Lonati, Silvia

AU - Novembrino, Cristina

AU - Bamonti, Fabrizia

AU - Tiriticco, Marco

AU - Fenoglio, Chiara

AU - Venturelli, Eliana

AU - Baron, Pierluigi

AU - Bresolin, Nereo

AU - Scarpini, Elio

PY - 2006/2

Y1 - 2006/2

N2 - Increasing evidence supports a role of oxidative imbalance, characterized by impaired antioxidant enzymatic activity and increased reactive oxygen species (ROS) production, in mild cognitive impairment (MCI) and Alzheimer's disease (AD) pathogenesis. Hyperhomocysteinemia, another risk factor for AD, also contributes to oxidative damage. Plasma total homocysteine (tHcy) and ROS levels, and total antioxidant capacity (TAC) were determined in 71 AD, 36 MCI and 28 vascular dementia (VaD) patients as well as in 44 age-matched controls. tHcy levels were significantly increased in patients with AD and VaD an a trend towards an increase in multiple domain MCI was observed. TAC was significantly decreased in AD as well as MCI, but not in VaD patients. In AD patients, a negative correlation was found between TAC and disease duration. ROS levels did not differ among groups, but were correlated with age. In conclusion, a pattern characterized by increased tHcy levels and decreased TAC is present in AD as well as MCI patients. While increased tHcy levels were also found in VaD, TAC modifications occur specifically in AD. ROS levels appear to be correlated with age rather than with a specific dementing disorder, thus leading to the hypothesis that oxidative imbalance observed in AD could be due to a decreased TAC.

AB - Increasing evidence supports a role of oxidative imbalance, characterized by impaired antioxidant enzymatic activity and increased reactive oxygen species (ROS) production, in mild cognitive impairment (MCI) and Alzheimer's disease (AD) pathogenesis. Hyperhomocysteinemia, another risk factor for AD, also contributes to oxidative damage. Plasma total homocysteine (tHcy) and ROS levels, and total antioxidant capacity (TAC) were determined in 71 AD, 36 MCI and 28 vascular dementia (VaD) patients as well as in 44 age-matched controls. tHcy levels were significantly increased in patients with AD and VaD an a trend towards an increase in multiple domain MCI was observed. TAC was significantly decreased in AD as well as MCI, but not in VaD patients. In AD patients, a negative correlation was found between TAC and disease duration. ROS levels did not differ among groups, but were correlated with age. In conclusion, a pattern characterized by increased tHcy levels and decreased TAC is present in AD as well as MCI patients. While increased tHcy levels were also found in VaD, TAC modifications occur specifically in AD. ROS levels appear to be correlated with age rather than with a specific dementing disorder, thus leading to the hypothesis that oxidative imbalance observed in AD could be due to a decreased TAC.

KW - Alzheimer's disease

KW - Mild cognitive impairment

KW - Reactive oxygen species

KW - Total antioxidant capacity

KW - Total plasma homocysteine

UR - http://www.scopus.com/inward/record.url?scp=29844435497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29844435497&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2005.01.001

DO - 10.1016/j.neurobiolaging.2005.01.001

M3 - Article

C2 - 16399211

AN - SCOPUS:29844435497

VL - 27

SP - 262

EP - 269

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 2

ER -